These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1902410)

  • 21. Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patients.
    Siperstein MD; Unger RH; Madison LL
    J Clin Invest; 1968 Sep; 47(9):1973-99. PubMed ID: 5675423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulfonylurea-induced decrease of muscle capillary basement membrane thickness in diabetes.
    Camerini-Davalos RA; Velasco CA; Glasser M; Bloodworth JM
    Diabetes Res Clin Pract; 1988 Jul; 5(2):113-23. PubMed ID: 3046878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of muscle capillary basement membrane thickness and diabetic retinopathy.
    Klein RF; Feingold KR; Morgan C; Stern WH; Siperstein MD
    Diabetes Care; 1987; 10(2):195-9. PubMed ID: 3582080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of diabetes-related retinal microangiopathy with aldose reductase inhibitors.
    Robison WG
    Adv Exp Med Biol; 1988; 246():365-72. PubMed ID: 3150650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of aldose reductase inhibitor (Ponalrestat) on erythrocyte Na,K-ATPase activity in non-insulin-dependent diabetic patients with polyneuropathy.
    Umeda F; Noda K; Hashimoto T; Yamashita T; Nawata H
    Diabetes Res; 1989 Nov; 12(3):125-9. PubMed ID: 2561396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat.
    Sima AA; Prashar A; Zhang WX; Chakrabarti S; Greene DA
    J Clin Invest; 1990 May; 85(5):1410-20. PubMed ID: 2110189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muscle capillary basement-membrane thickness and long-term glycemia in type I diabetes mellitus.
    Sosenko JM; Miettinen OS; Williamson JR; Gabbay KH
    N Engl J Med; 1984 Sep; 311(11):694-8. PubMed ID: 6472356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats.
    Tilton RG; Pugliese G; LaRose LS; Faller AM; Chang K; Province MA; Williamson JR
    J Diabet Complications; 1991; 5(4):230-7. PubMed ID: 1779018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muscle magnesium and capillary basement membrane thickness in diabetes mellitus.
    Dyckner T; Hägg E; Lithner F; Nyhlin H; Wester PO
    Diabete Metab; 1988; 14(5):619-22. PubMed ID: 3234585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and neurophysiological studies of aldose reductase inhibitor ponalrestat in chronic symptomatic diabetic peripheral neuropathy.
    Florkowski CM; Rowe BR; Nightingale S; Harvey TC; Barnett AH
    Diabetes; 1991 Jan; 40(1):129-33. PubMed ID: 1901808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of acarbose on diabetes- and age-related basement membrane thickening in retinal capillaries of the BB/W-rat.
    Chakrabarti S; Cherian PV; Sima AA
    Diabetes Res Clin Pract; 1993 May; 20(2):123-8. PubMed ID: 8375264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of sorbinil and ponalrestat (Statil) diminution of proteinuria in the BB rat.
    Beyer-Mears A; Murray FT; Cruz E; Rountree J; Sciadini M
    Pharmacology; 1992; 45(5):285-91. PubMed ID: 1465475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of myo-inositol treatment on basement membrane thickening in the BB/W-rat retina.
    Chakrabarti S; Sima AA
    Diabetes Res Clin Pract; 1992 Apr; 16(1):13-7. PubMed ID: 1576927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thickening of the capillary basement membrane of the quadriceps muscle in Vacor-induced diabetic patients.
    Lee TH; Choi KC; Park YK; Choi JK
    Diabetes Res Clin Pract; 1985 Oct; 1(3):155-9. PubMed ID: 3836103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The preventive effect of aldose reductase inhibition on diabetic optic neuropathy in the BB/W-rat.
    Kamijo M; Cherian PV; Sima AA
    Diabetologia; 1993 Oct; 36(10):893-8. PubMed ID: 8243866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective studies of muscle capillary basement membrane width in prediabetics.
    Feingold KR; Browner WS; Siperstein MD
    J Clin Endocrinol Metab; 1989 Oct; 69(4):784-9. PubMed ID: 2778035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of aldose reductase inhibition on erythrocyte polyols and galactitol accumulation in diabetic patients.
    Airey CM; Price DE; Kemp JV; Perkins CM; Wales JK
    Diabet Med; 1989 Dec; 6(9):804-8. PubMed ID: 2533041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Basement-membrane thickening and diabetic microangiopathy.
    Williamson JR; Kilo C
    Diabetes; 1976; 25(2 SUPPL):925-7. PubMed ID: 786763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Capillary basement membrane width in diabetic children.
    Raskin P; Marks JF; Burns H; Plumer ME; Siperstein MD
    Am J Med; 1975 Mar; 58(3):365-72. PubMed ID: 1115075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of aldose reductase inhibitor on retinal microangiopathy in streptozotocin-diabetic rats.
    Kojima K; Matsubara H; Harada T; Mizuno K; Suzuki M; Hotta N; Kakuta H; Sakamoto N
    Jpn J Ophthalmol; 1985; 29(1):99-109. PubMed ID: 3159927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.